Legend Biotech Corporation LEGN

US Biotechnology

$21.08 ▼ -13.22% ($-3.21)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $22.58

Prev Close $24.29

Day Range $20.61 – $22.86

52W Range $16.24 – $37.50

Market Cap $4.53B

Beta 0.56

EPS (TTM) $-0.25

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-06-04
Shares Out.	388,980,000
Website	legendbiotech.com/ ↗
Phone	17328505598
Employees	3,200
Revenue	$1.03B
Net Income	-$296.8M
Total Assets	$1.73B
Total Liabilities	$731.6M
Equity	$1.00B

About Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corporation is a publicly traded company under the ticker symbol LEGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.